跳至主要内容
临床试验/CTRI/2023/07/055156
CTRI/2023/07/055156已完成4 期

A Randomized, Open-Label, Single-Center Comparative Study to Evaluate Efficacy of Dente91 DB Toothpaste on Salivary Glucose and pH in Type 2 diabetic patients. ? - Nil

Frimline Private Limited0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Males and non-lactating females of age 18-65 (both inclusive).
  • 2. Patients with Type 2 DM with HbA1c of >8%.
  • 3. All the patients having minimum of 20 functional teeth in oral cavity will be included
  • 4. Patients of type 2 diabetes mellitus for more than one year, and taking mono / poly drug oral hypoglycemic agent(s) for at least last 3 months

排除标准

  • 1. Patients with any other systemic illness other than for diabetes which may hamper patient’s participation in the study as per investigator’s discretion.
  • 2. Patients with adverse habits (betel chewing, tobacco chewing, smoking and alcohol consumption).
  • 3. History of systemic antibiotic usage over the previous 4 months.
  • 4. Pregnant or lactating women.
  • 5. Use of orthodontic appliances.
  • 6. Patients with intake of supplemental Ascorbic acid.

研究者

发起方
Frimline Private Limited

相似试验

已完成
不适用
A Single Center, Open-label, Randomized Comparative Study to Evaluate the Effect of Aliskiren on Myocardial Perfusion Reserve and Coronary Flow Reserve in Hypertensive Patients with a history of Myocardial InfarctioHypertension
JPRN-UMIN000005511The University of Tokyo, department of cardiovascular medicine40
进行中(未招募)
1 期
A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection.Complicated Intra-Abdominal Infection
EUCTR2005-000448-99-GRWyeth Pharmaceuticals, Inc., Global Medical Affairs430
进行中(未招募)
不适用
A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection.Complicated Intra-Abdominal Infection
EUCTR2005-000448-99-DKWyeth Pharmaceuticals, Inc., Global Medical Affairs430
进行中(未招募)
不适用
A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal InfectioComplicated intra-abdominal infectionsMedDRA version: 9.1Level: HLTClassification code 10017967Term: Abdominal and gastrointestinal infections
EUCTR2005-000448-99-ITWYETH LEDERLE30
进行中(未招募)
1 期
A Multicenter, Open-Label, Randomized Comparative Study of Tigecycline vs Ceftriaxone Sodium Plus Metronidazole for the Treatment of Hospitalized Subjects With Complicated Intra-abdominal Infection.Estudio comparativo abierto, aleatorizado, multicéntrico de Tigeciclina frente a Ceftriaxona Sódica más Metronidazol en el tratamiento de pacientes hospitalizados con infección intraabdominal complicada.Complicated Intra-Abdominal Infection
EUCTR2005-000448-99-ESWyeth Pharmaceuticals, Inc., Global Medical Affairs430